SMMTSummit Therapeutics Inc.
$15.46-30% 1Y
$15.46
$12.4252 weeks$26.38
Is the business good?
Mixed
1 neutral, 3 without dataMargins steady. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margin direction, 3 yearsStablederived
Margins have held roughly steady, a stable cost structure.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is SMMT?
- Share count, year on year
- +4.8%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | −6185% |
| FY2021 | −4764% |
| FY2022 | −10225% |
Details›
- Free cash flow, trailing twelve months
- −$460M
- Net income, trailing twelve months
- −$856M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.